摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 5-amino-6-((trimethylsilyl)ethynyl)picolinate | 1346569-64-9

中文名称
——
中文别名
——
英文名称
ethyl 5-amino-6-((trimethylsilyl)ethynyl)picolinate
英文别名
ethyl 5-amino-6-[2-(trimethylsilyl)ethynyl]pyridine-2-carboxylate;Ethyl 5-amino-6-(2-trimethylsilylethynyl)pyridine-2-carboxylate
ethyl 5-amino-6-((trimethylsilyl)ethynyl)picolinate化学式
CAS
1346569-64-9
化学式
C13H18N2O2Si
mdl
——
分子量
262.384
InChiKey
RQNMNDRBBVTPTJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.07
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    65.2
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 5-amino-6-((trimethylsilyl)ethynyl)picolinate吡啶 、 lithium aluminium tetrahydride 、 四丁基氟化铵 、 sodium hydride 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 12.17h, 生成 (1-tosyl-1H-pyrrolo[3,2-b]pyridin-5-yl)methyl 4-methylbenzenesulfonate
    参考文献:
    名称:
    Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists
    摘要:
    We report the design and synthesis of novel 5,6-diarylated pyridin-2(1H)-one derivatives as pharmacophoric PDE10A inhibitors. This highly potent molecular scaffold was developed from an inactive diarylpyridine-2-amine derivative 3b by extensive and systematic analogue synthesis and SAR analysis. Further optimization of the scaffold resulted in identification of pyridin-2(1H)-one 18b as a lead compound with good potency (IC50 = 1.6 nM) and selectivity (>6000-fold) over other related PDEs but with a poor pharmacokinetic profile. Careful metabolite profiling of 18b revealed that poor systemic exposure in rats (C-max = 44 ng/mL; AUC(0-t), = 359 ng.h/mL) at 10 mg/kg was due to the formation of O-glucuronide conjugate by phase 2 metabolism. The structure of the glucuronide metabolite was confirmed by retention time and LC-MS/MS fragmentation matching with the synthetic glucuronide 26. The problem of low exposure of 18b was effectively addressed by its conversion to an acetate prodrug 25b, which upon oral dosing resulted in an improved pharmacokinetic profile (C-max = 359 ng.h/mL; AUC(0-t), = 2436 ng.h/mL) and a desirable brain to plasma ratio of 1.2. The prodrug 25b showed good efficacy in selected rodent models of psychosis.
    DOI:
    10.1021/acs.jmedchem.5b01240
  • 作为产物:
    描述:
    ethyl 5-amino-6-iodopyridine-2-carboxylate 、 三甲基乙炔基硅 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 三乙胺 作用下, 生成 ethyl 5-amino-6-((trimethylsilyl)ethynyl)picolinate
    参考文献:
    名称:
    [EN] ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS
    [FR] COMPOSÉS OLÉFINIQUES À SUBSTITUTION ARYLE EN TANT QU'INHIBITEURS DE LA PDE10A
    摘要:
    本发明提供了芳基取代烯烃化合物作为磷酸二酯酶1 0A(PDE 1 0A)抑制剂。具体来说,本文描述的化合物可用于通过抑制磷酸二酯酶1 0A酶来治疗或预防疾病、症状和/或紊乱。本文还提供了用于制备本文描述的化合物的工艺、用于合成的中间体以及它们的药物组合物。
    公开号:
    WO2011138657A1
点击查看最新优质反应信息

文献信息

  • [EN] ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS<br/>[FR] COMPOSÉS OLÉFINIQUES À SUBSTITUTION ARYLE EN TANT QU'INHIBITEURS DE LA PDE10A
    申请人:GLENMARK PHARMACEUTICALS SA
    公开号:WO2011138657A1
    公开(公告)日:2011-11-10
    The present invention provides aryl substituted olefinic compounds as Phosphodiesterase 1 0A (PDE 1 0A) inhibitors. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders by inhibiting Phosphodiesterase 1 0A enzyme. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof.
    本发明提供了芳基取代烯烃化合物作为磷酸二酯酶1 0A(PDE 1 0A)抑制剂。具体来说,本文描述的化合物可用于通过抑制磷酸二酯酶1 0A酶来治疗或预防疾病、症状和/或紊乱。本文还提供了用于制备本文描述的化合物的工艺、用于合成的中间体以及它们的药物组合物。
  • Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1<i>H</i>)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists
    作者:V. S. Prasadarao Lingam、Dnyaneshwar H. Dahale、Vijay E. Rathi、Yogesh B. Shingote、Rajni R. Thakur、Ajit S. Mindhe、Srinivas Kummari、Neelima Khairatkar-Joshi、Malini Bajpai、Daisy M. Shah、Ratika S. Sapalya、Srinivas Gullapalli、Praveen K. Gupta、Girish S. Gudi、Satyawan B. Jadhav、Rambabu Pattem、Abraham Thomas
    DOI:10.1021/acs.jmedchem.5b01240
    日期:2015.10.22
    We report the design and synthesis of novel 5,6-diarylated pyridin-2(1H)-one derivatives as pharmacophoric PDE10A inhibitors. This highly potent molecular scaffold was developed from an inactive diarylpyridine-2-amine derivative 3b by extensive and systematic analogue synthesis and SAR analysis. Further optimization of the scaffold resulted in identification of pyridin-2(1H)-one 18b as a lead compound with good potency (IC50 = 1.6 nM) and selectivity (>6000-fold) over other related PDEs but with a poor pharmacokinetic profile. Careful metabolite profiling of 18b revealed that poor systemic exposure in rats (C-max = 44 ng/mL; AUC(0-t), = 359 ng.h/mL) at 10 mg/kg was due to the formation of O-glucuronide conjugate by phase 2 metabolism. The structure of the glucuronide metabolite was confirmed by retention time and LC-MS/MS fragmentation matching with the synthetic glucuronide 26. The problem of low exposure of 18b was effectively addressed by its conversion to an acetate prodrug 25b, which upon oral dosing resulted in an improved pharmacokinetic profile (C-max = 359 ng.h/mL; AUC(0-t), = 2436 ng.h/mL) and a desirable brain to plasma ratio of 1.2. The prodrug 25b showed good efficacy in selected rodent models of psychosis.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-